跳至主要内容
临床试验/NCT06965192
NCT06965192招募中不适用

Designing Visual Tools to Enhance Cancer Surgeon Decision-making

UNC Lineberger Comprehensive Cancer Center4 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2025年4月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
220
试验地点
4
主要终点
Discussion of Risks and Benefits

研究概览

简要总结

This prospective study will compare pre-post pilot test of surgeon-facing, visual decision support among urologists seeing patients with newly diagnosed localized prostate and kidney cancer. Up to 20 urologists (10 academic and 10 community) will be enrolled. The goal will be to capture up to 10 pre- and 10 post-intervention patient encounters for each urologist with an accrual target of 200 unique patient visits (100 pre and 100 post-intervention) over a half-year period. Patient encounters pre- and post-intervention will be audio recorded, transcribed, and coded for discussion of risks/benefits of surgery and strength of recommendation. Patients and urologists will complete additional surveys on their perceptions of patient-provider communication. Urologists will further describe their experience and rate their satisfaction with visual decision support. Communication (content and perceived) will be compared pre- and post-intervention with secondary comparisons by race and care setting.

It was hypothesized that the discussion of risks and benefits of cancer surgery will increase post-intervention and that the strength of recommendation and perceptions of patient-provider communication will change. The secondary hypothesis is that these changes will differ by patient race and care setting.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •In order to participate in this study, a subject must meet all of the eligibility criteria outlined below.
  • •Verbal informed consent was obtained to participate in the study.
  • •Subject is willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
  • •Age ≥ 18 years at the time of consent.
  • •For patient subjects, HIPAA authorization for the release of personal health information and a new histologic diagnosis of localized prostate cancer based on prostate biopsy or clinical diagnosis of T1 renal mass (≤7 cm in diameter) Suspicion for kidney cancer based on cross-sectional imaging. New diagnosis is defined as within 6 months of consent. T1 renal masses include solid masses or Bosniak III/IV cystic masses.
  • •For physician subjects, practicing urologist in North Carolina at UNC Health, Novant Health, or an affiliated site and sees patients with suspected or confirmed prostate or kidney cancer.

排除标准

  • •The subjects meeting the following criteria will be excluded from study participation:
  • •Non-English speaking.
  • •Unwilling or unable to complete informed consent.
  • •For patient subjects:
  • •Has staging information indicating locally advanced or metastatic disease. This would include PSA >50 ng/ml, imaging suggestive of distant metastasis, or lymph node involvement, renal masses >7 cm or invading in renal sinus or tumor thrombus.
  • •Histologic or clinical diagnosis >6 months before date of consent.

研究组 & 干预措施

Patient participants

Experimental

Patient participants will complete a 10-minute baseline survey, 15-minute after-visit survey and 5-minute 6-month survey.

干预措施: No intervention (Other)

Physician participants

Experimental

Physician participants seeing patients with newly diagnosed localized prostate cancer and clinical T1 renal masses suspicious for kidney cancer.

干预措施: Visual (Behavioral)

结局指标

主要结局

Discussion of Risks and Benefits

时间窗: Baseline (Patient-Physician Encounter)

The impact of visual decision support on patient-physician communication will be assessed using coding-based thematic analysis of the debriefing interviews. The Informed Decision-Making coding system, which includes 9 elements which includes the nature of the clinical problem (e.g., cancer mortality risk, life expectancy), treatment options (e.g., surgery, alternatives), risks and benefits (e.g., complications, side effects, functional outcomes), and uncertainties (e.g., range of possible outcomes). Audio-recorded patient encounters will be coded. Paired coders will score these domains as a 0 (absent), 1 (partial, brief, or one-way), or 2 (complete, two-way discussion).

次要结局

  • The impact of the visual decision support on the strength of the recommendations - observer(Baseline (Patient-Physician Encounter))
  • The impact of the visual decision support on the strength of the recommendations - surgeon rated(Baseline (After-Visit))
  • Patient-Centered Communication(Baseline (After-Visit))
  • Physician Satisfaction Scale(Baseline (After-Visit))
  • Patient-Physician Communication(Baseline (After-Visit))
  • Patient Decision-Making(Up to 6 months)
  • Physician Decision-Making(Baseline (After-Visit))
  • Treatment Selection/Quality(Up to12 months)
  • Perceived Usability Ratings(Up to 6 months)
  • Physician Debriefing Interview(Up to 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验